<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>431-PROBENECID.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="PROBENECID" rxcui="8698">
<ATC code="M04AB01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="ACETYLSALICYLIC ACID" rxcui="1191">
<ATC code="A01AD05" />
<ATC code="B01AC06" />
<ATC code="N02BA01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the uricosuric effect due to competition of the elimination of the uric acid at the level of the renal tubules</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>431-PROBENECID.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="PROBENECID" rxcui="8698">
<ATC code="M04AB01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="DIPROPHYLLINE" rxcui="3714">
<ATC code="R03DA01" />
<ATC code="R03DB01" />
<ATC code="R03DA51" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of overdose due to increase of the plasma concentrations of diprophylline (inhibition of its renal tubular secretion)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>431-PROBENECID.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="PROBENECID" rxcui="8698">
<ATC code="M04AB01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="METHOTREXATE" rxcui="6851">
<ATC code="L01BA01" />
<ATC code="L04AX03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the toxicity of the methotrexate: inhibition of the renal tubular secretion of the methotrexate by the probenecid</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
</INTERACTIONS>
